In vitro activities of faropenem, ertapenem, imipenem and meropenem against Borrelia burgdorferi s.l.

International Journal of Antimicrobial Agents

Volumn 30, Issue 1, 2007, Pages 83-86

  Rödel, Rebecca ^a   Freyer, Alexandra ^a   Bittner, Thomas ^a   Schäfer, Volker ^a   Hunfeld, Klaus Peter ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Borrelia burgdorferi; Carbapenems; In vitro activity; Penems; Spirochetes; Susceptibility testing

Indexed keywords

CEFTRIAXONE; ERTAPENEM; FROPENEM; IMIPENEM; MEROPENEM; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BORRELIA BURGDORFERI; CONTROLLED STUDY; IN VITRO STUDY; LYME DISEASE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; BORRELIA BURGDORFERI GROUP; COLONY COUNT, MICROBIAL; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; TIME FACTORS;

EID: 34249864523     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.03.008     Document Type: Article

References (10)

1. Bonfiglio G., Russo G., and Nicoletti G. Recent developments in carbapenems. Expert Opin Investig Drugs 11 (2002) 529-544
2. Dalhoff A., Janjic N., and Echols R. Redefining penems. Biochem Pharmacol 71 (2006) 1085-1095
3. Hunfeld K.P., and Brade V. Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know. Wien Klin Wochenschr 118 (2006) 659-668
4. Hunfeld K.P., Rödel R., and Wichelhaus T.A. In vitro activity of eight oral cephalosporins against Borrelia burgdorferi. Int J Antimicrob Agents 21 (2003) 313-318
5. Kraiczy P., Weigand J., Wichelhaus T.A., et al. In vitro activity of fluoroquinolones against the spirochete Borrelia burgdorferi. Antimicrob Agents Chemother 45 (2001) 2486-2494
6. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 7th ed. Approved standard. M7-A7. Document M100-S16. Wayne, PA: CLSI; 2006.
7. Hunfeld K.P., Wichelhaus T.A., Rödel R., Acker G., Brade V., and Kraiczy P. Comparison of in vitro activities of ketolides, macrolides, and an azalide against the spirochete Borrelia burgdorferi. Antimicrob Agents Chemother 48 (2004) 344-347
8. Sohaskey C.D., and Barbour A.G. Esterases in serum-containing growth media counteract chloramphenicol acetyltransferase activity in vitro. Antimicrob Agents Chemother 43 (1999) 655-660
9. Laethem T., De Lepeleire I., McCrea J., et al. Tissue penetration by ertapenem, a parenteral carbapenem administered once daily, in suction-induced skin blister fluid in healthy young volunteers. Antimicrob Agents Chemother 47 (2003) 1439-1442
10. Wormser G.P., Dattwyler R.J., Shapiro E.D., et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43 (2006) 1089-1134